Press Release

The ERISA Industry Committee Outlines Objectives and Ongoing Pursuits to Protect and Enhance Employee Benefits

Issued by ERIC [ERISA Industry Committee]

Jan. 24, 2023

WASHINGTON, DC – The ERISA Industry Committee (ERIC) today announced it looks forward to working with the 118th Congress on policies protecting and enhancing employee health care and retirement benefits.

In a letter sent to Capitol Hill, ERIC celebrated the 117th Congress’ work to accomplish several critical objectives, including:

• Extending 1st-dollar coverage of telehealth in high-deductible health plans until December 31, 2024
• Expanding and improving mental health programs through the passage of the Restoring Hope for Mental Health and Wellbeing Act
• Enhancing retirement policy with inclusion of the SECURE 2.0 Act in the Consolidated Appropriations Act of 2023

ERIC also shared its eagerness to continue advancing legislative solutions that would benefit  workers, retirees, and their families, outlined in its policy priorities, which are focused on:

• Improving employee health and financial security
• Increasing flexibility and opportunity
• Reducing costs and administrative burdens
• Helping large employers continue to deliver uniform, national benefits programs related to health care, retirement, paid leave, and compensation

“ERIC will work diligently to ensure that large employers can provide robust, affordable, high-value employee benefits to their workforce. There has never been a more important time to ensure that workers and their families are healthy and have access to high-quality, affordable health care and a financially secure retirement. We look forward to working with Congress to support these important goals, and to serve as a resource during the 118th Congress,” said James Gelfand, President of ERIC.

Editor's note: This press release has been issued by the company named above, not BenefitsLink. Reliance on information in this press release might be prudent only after an independent review of its accuracy, completeness, efficacy, and timeliness. Reference to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer, or otherwise does not constitute or imply endorsement, recommendation, or favoring by BenefitsLink.